123 related articles for article (PubMed ID: 20451577)
1. Identification and consequences of galectin-3 expression in pituitary tumors.
Righi A; Jin L; Zhang S; Stilling G; Scheithauer BW; Kovacs K; Lloyd RV
Mol Cell Endocrinol; 2010 Sep; 326(1-2):8-14. PubMed ID: 20451577
[TBL] [Abstract][Full Text] [Related]
2. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of galectin-3 in pituitary tumors.
Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
[TBL] [Abstract][Full Text] [Related]
5. RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.
Zhang HY; Jin L; Stilling GA; Ruebel KH; Coonse K; Tanizaki Y; Raz A; Lloyd RV
Endocrine; 2009 Feb; 35(1):101-11. PubMed ID: 19020999
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
7. Reduction of galectin-3 expression reduces pituitary tumor cell progression.
Huang CX; Zhao JN; Zou WH; Li JJ; Wang PC; Liu CH; Wang YB
Genet Mol Res; 2014 Aug; 13(3):6892-8. PubMed ID: 25177969
[TBL] [Abstract][Full Text] [Related]
8. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
9. Proliferation markers of human pituitary tumors: contribution of a genome-wide transcriptome approach.
Wierinckx A; Raverot G; Nazaret N; Jouanneau E; Auger C; Lachuer J; Trouillas J
Mol Cell Endocrinol; 2010 Sep; 326(1-2):30-9. PubMed ID: 20211685
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
Mazurek N; Sun YJ; Price JE; Ramdas L; Schober W; Nangia-Makker P; Byrd JC; Raz A; Bresalier RS
Cancer Res; 2005 Dec; 65(23):10767-75. PubMed ID: 16322222
[TBL] [Abstract][Full Text] [Related]
11. Runx2 is expressed in human glioma cells and mediates the expression of galectin-3.
Vladimirova V; Waha A; Lückerath K; Pesheva P; Probstmeier R
J Neurosci Res; 2008 Aug; 86(11):2450-61. PubMed ID: 18438928
[TBL] [Abstract][Full Text] [Related]
12. Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
Devouassoux-Shisheboran M; Deschildre C; Mauduit C; Berger G; Mejean-Lebreton F; Bouvier R; Droz JP; Fénichel P; Benahmed M
Oncol Rep; 2006 Aug; 16(2):335-40. PubMed ID: 16820912
[TBL] [Abstract][Full Text] [Related]
13. A novel apoptosis gene identified in the pituitary gland.
Farrell WE
Neuroendocrinology; 2006; 84(4):217-21. PubMed ID: 17135715
[TBL] [Abstract][Full Text] [Related]
14. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
15. ZAC1 target genes and pituitary tumorigenesis.
Theodoropoulou M; Stalla GK; Spengler D
Mol Cell Endocrinol; 2010 Sep; 326(1-2):60-5. PubMed ID: 20117169
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of pituitary neoplasms.
Sav A; Rotondo F; Syro LV; Scheithauer BW; Kovacs K
Anticancer Res; 2012 Nov; 32(11):4639-54. PubMed ID: 23155226
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of survivin and PCNA in pituitary tumors and normal pituitary.
Wasko R; Waligorska-Stachura J; Jankowska A; Warchol JB; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2009; 30(4):477-81. PubMed ID: 20010504
[TBL] [Abstract][Full Text] [Related]
18. Chromatin remodeling and histone modifications in pituitary tumors.
Tateno T; Zhu X; Asa SL; Ezzat S
Mol Cell Endocrinol; 2010 Sep; 326(1-2):66-70. PubMed ID: 20060434
[TBL] [Abstract][Full Text] [Related]
19. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of pituitary tumors.
Farrell WE; Clayton RN
Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
